Combined Intravenous and Intraarticular Tranexamic Acid Does Not Offer Additional Benefit Compared with Intraarticular Use Alone in Bilateral TKA: A Randomized Controlled Trial

BACKGROUND: Tranexamic acid (TXA) is efficacious for reducing blood loss and transfusion use in patients who undergo bilateral TKA, and it is administered intravenously alone, intraarticularly alone, or as a combination of these. However, it is unclear whether combined intravenous (IV) and intraarti...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Orthop Relat Res
Main Authors: Meshram, Prashant, Palanisamy, Jeya Venkatesh, Seo, Jong Yeon, Lee, Jong Geun, Kim, Tae Kyun
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer 2020
Assuntos:
Clinical Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7000050/
https://ncbi.nlm.nih.gov/pubmed/31498264
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CORR.0000000000000942
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados